Meet the Precision
AQ team at ASCO 2026

Chicago, IL | May 29 - June 2, 2026

ASCO 2026

Precision AQ is a commercialization partner for biopharma innovators, market access teams, and brand strategists. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity. 

Our proprietary Access Made Possible technology integrates payer, provider, and patient insights to deliver scalable, actionable strategies that widen access to innovation. At Precision AQ, we believe access is earned with evidence, empathy, and precision. 

Drop by our booth #11059 or complete the form below to book a meeting with our experts at ASCO. 

Schedule time to meet our expert team

at ASCO 2026. 

Our expertise spans route-of-administration strategies, site-of-care dynamics, and evolving specialty distribution models. We deliver strategy development, value demonstration, and stakeholder engagement anchored in real-world oncology insights and deep clinical and economic expertise. From navigating buy-and-bill complexities to designing impactful patient support programs, we build access solutions that meet the demands of today’s oncology market. 
 
Complete the form to book a meeting, and we’ll reach out to confirm the details. 


Meet Our Oncology Experts Onsite

Greg Gregory_Small (1) Greg Gregory B&W

Greg Gregory, PhD

Hannah Deresiewicz_AQ_full Hannah Deresiewicz BW

Hannah Deresiewicz

Lauren Westburg Lauren Westburg BW

Lauren Westburg

Thad Nowakowski_AQ_full Thad Nowakowski BW

Thad Nowakowski

Julianna Kula_AQ_full-1 Julianna Kula BW

Julianna Kula, PharmD, BCOP

Madeline_Waldron 2023 AQ_full Madeline Waldron BW (1)

Madeline Waldron, PharmD, BCOP

Stephanie Kennedy_AQ_sm Stephanie Kennedy_AQ_sm BW

Stephanie Kennedy, PhD

Leanne Larson Leanne Larson-BW

Leanne Larson, MHA

Elizabeth Grogan_AQ-full Elizabeth Grogan BW

Liz Grogan, PhD

Jennifer Williams_AQ_full Jennifer Williams BW

Jennifer Williams, PhD, BCOP

Schedule a Meeting

Explore our blog

Why IDNs Are Becoming the Most Important Access Stakeholder
Using Predictive Analytics to Anticipate Access Change
Advancing Real-World Evidence in HEOR: A Q&A With Experts